Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. GMRE
stocks logo

GMRE

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
37.77M
+7.44%
0.000
-100%
38.68M
+11.72%
0.190
+26.67%
39.22M
+3.3%
0.000
-100%
Estimates Revision
The market is revising Upward the revenue expectations for Global Medical REIT Inc. (GMRE) for FY2025, with the revenue forecasts being adjusted by 0.23% over the past three months. During the same period, the stock price has changed by -13.97%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.23%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-204%
In Past 3 Month
Stock Price
Go Down
down Image
-13.97%
In Past 3 Month
Wall Street analysts forecast GMRE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GMRE is 40.70 USD with a low forecast of 35.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast GMRE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GMRE is 40.70 USD with a low forecast of 35.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 32.690
sliders
Low
35.00
Averages
40.70
High
50.00
Current: 32.690
sliders
Low
35.00
Averages
40.70
High
50.00
Baird
Neutral
downgrade
$45 -> $41
2025-11-11
Reason
Baird
Price Target
$45 -> $41
2025-11-11
downgrade
Neutral
Reason
Baird lowered the firm's price target on Global Medical REIT to $41 from $45 and keeps a Neutral rating on the shares. The firm updated its model following Q3 results which suggest the tough capital markets may lead to asset recycling.
Alliance Global Partners
Gaurav Mehta
Buy
downgrade
2025-05-29
Reason
Alliance Global Partners
Gaurav Mehta
Price Target
2025-05-29
downgrade
Buy
Reason
BMO Capital
Market Perform
downgrade
2025-05-26
Reason
BMO Capital
Price Target
2025-05-26
downgrade
Market Perform
Reason
BMO Capital lowered the firm's price target on Global Medical REIT to $7.50 from $9.50 and keeps a Market Perform rating on the shares. The firm made changes to its models for a number of REITs due to interest rate changes, recent results, and/or discussions with company management.
Baird
Neutral
downgrade
$10 -> $9
2025-05-08
Reason
Baird
Price Target
$10 -> $9
2025-05-08
downgrade
Neutral
Reason
Baird lowered the firm's price target on Global Medical REIT to $9 from $10 and keeps a Neutral rating on the shares. The firm updated its model following Q1 results which were ahead due to NOI and guidance was unchanged.
Alliance Global Partners
Gaurav Mehta
Buy
downgrade
$11
2025-05-08
Reason
Alliance Global Partners
Gaurav Mehta
Price Target
$11
2025-05-08
downgrade
Buy
Reason
Alliance Global Partners analyst Gaurav Mehta lowered the firm's price target on Global Medical REIT to $9.50 from $11 and keeps a Buy rating on the shares. While there was a decline in occupancy in Q1 and management comments indicate that there could be further decline in occupancy in Q2 and Q3, the company noted that there could be improvement by the end of 2025, the analyst tells investors in a research note. The firm believes that an improved portfolio performance could be a positive catalyst for the stock, adding that it views the current valuation as attractive and believes risk/reward is skewed to the upside at current pricing.
Citizens Capital Markets
Aaron Hecht
Hold
Reiterates
n/a
2025-03-12
Reason
Citizens Capital Markets
Aaron Hecht
Price Target
n/a
2025-03-12
Reiterates
Hold
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Global Medical REIT Inc (GMRE.N) is 148.59, compared to its 5-year average forward P/E of 65.56. For a more detailed relative valuation and DCF analysis to assess Global Medical REIT Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
65.56
Current PE
148.59
Overvalued PE
313.98
Undervalued PE
-182.86

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
13.76
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
15.47
Undervalued EV/EBITDA
12.05

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
5.04
Current PS
0.00
Overvalued PS
6.65
Undervalued PS
3.43
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders areBuying! The selling amount has increased 4132.36% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areBuying! The selling amount has increased 4132.36% over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

GMRE News & Events

Events Timeline

(ET)
2025-11-04
16:10:21
Global Medical REIT Announces Q3 FFO of $1.00, Below Consensus Estimate of $1.05
select
2025-08-13 (ET)
2025-08-13
16:16:42
Global Medical REIT announces $50M buyback, 1-for-5 reverse stock split
select
2025-08-05 (ET)
2025-08-05
16:49:34
Global Medical REIT reports Q2 adjusted FFO 23c, consensus 23c
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
8.0
00:45 AMSeekingAlpha
Global Medical REIT Announces $0.75 Dividend Payment

  • Quarterly Dividend Announcement: Global Medical REIT (GMRE) has declared a quarterly dividend of $0.75 per share, with a forward yield of 9.19%.

  • Dividend Payment Details: The dividend is payable on January 9, for shareholders of record on December 19, with an ex-dividend date also set for December 19.

  • Preferred Stock Offering: GMRE has priced a new preferred stock offering at $50 million, with shares priced at $25.00 each.

  • Market Activity: AEW Capital has exited six REITs in Q3 and initiated a position in American Tower, indicating shifts in investment strategies within the REIT sector.

[object Object]
Preview
8.5
11-14Newsfilter
Global Medical REIT Inc. Sets Price for Public Offering of 8.00% Series B Preferred Stock

  • Public Offering Announcement: Global Medical REIT Inc. has priced an underwritten public offering of 2,000,000 shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, aiming to raise approximately $50 million before expenses, with the offering expected to close on November 20, 2025.

  • Use of Proceeds: The net proceeds from the offering will be utilized for general corporate purposes, which may include funding new acquisitions and repaying existing debt.

  • Underwriters and Listing: The offering is managed by several financial institutions, and the Company plans to list the Series B Preferred Stock on the New York Stock Exchange under the symbol "GMRE PrB."

  • Forward-Looking Statements: The press release includes forward-looking statements regarding the offering's closing, use of proceeds, and listing, which are subject to risks and uncertainties that could lead to different outcomes than anticipated.

[object Object]
Preview
8.5
11-14SeekingAlpha
Global Medical Announces $50M Preferred Stock Offering at $25.00 per Share

  • Public Offering Announcement: Global Medical REIT (GMRE) has priced an underwritten public offering of 2 million shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, aiming to raise approximately $50 million before expenses.

  • Use of Proceeds: The net proceeds from the offering will be used for general corporate purposes, including funding new acquisitions and repaying existing debt.

  • Closing Date: The transaction is expected to close on November 20, 2025, with underwriters granted a 30-day option to purchase an additional 300,000 shares.

  • Stock Exchange Listing: GMRE plans to apply for the new Series B Preferred Stock to be listed on the New York Stock Exchange under the ticker symbol "GMRE PrB."

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Global Medical REIT Inc (GMRE) stock price today?

The current price of GMRE is 32.69 USD — it has decreased -1.86 % in the last trading day.

arrow icon

What is Global Medical REIT Inc (GMRE)'s business?

Global Medical REIT Inc. is an internally managed real estate investment trust (REIT). The Company acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. The Company conducts its business through a wholly owned subsidiary of its operating partnership, Global Medical REIT L.P. It owns 92.6% of the outstanding common operating partnership units (OP Units) of its operating partnership, with an aggregate of 7.4% of the Operating Partnership owned by holders of long-term incentive plan units (LTIP Units) and third-party limited partners who contributed properties or services to the operating partnership in exchange for OP Units. Its portfolio includes medical office buildings (MOBs), inpatient rehab. facility (IRF), surgical hospitals and others. The Company's portfolio is located in various areas, including Texas, Florida, Ohio, Pennsylvania, Illinois, Arizona, and Michigan.

arrow icon

What is the price predicton of GMRE Stock?

Wall Street analysts forecast GMRE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GMRE is 40.70 USD with a low forecast of 35.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Global Medical REIT Inc (GMRE)'s revenue for the last quarter?

Global Medical REIT Inc revenue for the last quarter amounts to 37.23M USD, increased 8.65 % YoY.

arrow icon

What is Global Medical REIT Inc (GMRE)'s earnings per share (EPS) for the last quarter?

Global Medical REIT Inc. EPS for the last quarter amounts to -0.45 USD, decreased -421.43 % YoY.

arrow icon

What changes have occurred in the market's expectations for Global Medical REIT Inc (GMRE)'s fundamentals?

The market is revising Upward the revenue expectations for Global Medical REIT Inc. (GMRE) for FY2025, with the revenue forecasts being adjusted by 0.23% over the past three months. During the same period, the stock price has changed by -13.97%.
arrow icon

How many employees does Global Medical REIT Inc (GMRE). have?

Global Medical REIT Inc (GMRE) has 26 emplpoyees as of December 05 2025.

arrow icon

What is Global Medical REIT Inc (GMRE) market cap?

Today GMRE has the market capitalization of 438.29M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free